Ondansetron ODT 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25F6SNX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,328
Award facts
- Contract value 100% obligated
- $4,328.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement that extends through December 2026 and enables the company to supply medications, vaccines, medical devices, and related healthcare commodities to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor providing medications and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capacity to fulfill varying order sizes and medical product requirements through open competition. Ondansetron is an antiemetic medication commonly used in medical settings to prevent nausea and vomiting, particularly in military and veteran healthcare applications. This delivery order exemplifies the ongoing operational demand for essential pharmaceutical products within the federal medical supply chain to support deployed and domestic military personnel.
Quick answers
Who was awarded contract SPE2DX25F6SNX?
SPE2DX25F6SNX was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 30, 2025.
How much is contract SPE2DX25F6SNX worth?
The government has obligated $4,328 on SPE2DX25F6SNX.
Is contract SPE2DX25F6SNX an order under another contract?
Yes. SPE2DX25F6SNX is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6SNX competed?
The extent of competition for SPE2DX25F6SNX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award